INmune Bio Inc. Common stock (INMB) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for INmune Bio Inc. Common stock, updated every trading day.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
Price
$1.53
+0.66% today
Market cap
$42M
Overall quality
—
Kronos AI 30-day
+5.9%
8 of 8 simulated paths end higher
INmune Bio Inc. Common stock (INMB) is a Health Care company in Biotechnology: Biological Products (No Diagnostic Substances), worth $42M. It trades at $1.53, up 0.66% today. 1 analysts' average target of $8.00 implies +422.9% from today's price. Kronos AI's 30-day forecast is +5.9% (8 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $8.00 |
| Low – high | $8.00 – $8.00 |
| Analysts | 1 |
| Upside to average | +422.9% |
Kronos AI 30-day forecast
| Expected close | $1.61 (+5.9%) |
| Likely range | +0.7% … +9.9% |
| As of | 2026-10-27 |
8 of 8 simulated paths end higher.
Quality scores
Not scored: the financial data for this listing is incomplete.
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Biological Products (No Diagnostic Substances)
For information only, not investment advice. Prices updated: 2026-10-29.